Announcing ERBB2 (HER2/neu) Gene Amplification by Dual ISH
Breast CancerTest

Breast CancerEffective January 22, 2013, ARUP is now offering the
ERBB2 (HER2/neu) Gene Amplification by Dual ISH breast cancer test.

ARUP Test code: 2007410

 

 

  • FDA-approved, INFORM HER2 Dual ISH assay.
  • As accurate and specific as FISH with fewer repeats and failures.*
  • Improved turn-around time. Result to be reported within three to five days.
  • Bright-field, whole-slide analysis. Enables pathologist to better visualize tumor morphology. No signal fading allows for archiving slides and sharing digital images with clients.
  • Same price as HER2 FISH assay.

* Based on ARUP internal validation studies.

To learn more about's ARUP's Breast Cancer test menu, see our Oncology Breast Cancer page:
http://aruplab.com/oncology/tests/breast